Mantle Cell Lymphoma (MCL) Completed Phase 2 Trials for Entospletinib (DB12121)

Also known as: Lymphoma, Mantle-Cell / Mantle Cell Lymphoma / Mantle-Cell Lymphoma / Lymphoma, Mantle- Cell / Lymphoma, Mantle Cell / Mantle-Cell Lymphomas / B cell lymphoma / Centrocytic lymphoma / Mantle cell lymphoma NOS / Mantle cell lymphomas

DBCOND0071979 (Mantle Cell Lymphoma (MCL))Completed2 IdentifierTitlePurposeDrugs
NCT01796470Entospletinib in Combination With Idelalisib in Adults With Relapsed or Refractory Hematologic MalignanciesTreatment